Katy Jeannot - Concepedia

Author

Katy Jeannot

Centre Hospitalier Universitaire de Besançon ORCID

Also Known As

Christophe Henry, Jeannot, Katy, Jeannot, Katya Kavuya, K Jeannot, K. Jeannot, Katy Jeannot, Katya Kavuya Jeannot, Sylvain Goutelle, Véronique Dubois

109

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier Universitaire de Besançon Centre National de la Recherche Scientifique CNR de la Résistance aux Antibiotiques Université de franche-comté

About

Katy Jeannot is an author at Centre Hospitalier Universitaire de Besançon specializing in medicine, microbiology, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	23	2.1K
2	Health Sciences	15	17	1.4K
3	Engineering	1	1	25
4	Natural Sciences	1	1	55
5	Social Sciences	1	1	55

Katy Jeannot

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study Caroline Charlier, Élodie Perrodeau, Alexandre Leclercq, The Lancet Infectious Diseases Prognostic FactorsFoodborne IllnessClinical FeaturesMicrobiologyInfection Control	2017	556
Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins Meryem Berrazeg, Katy Jeannot, Véronique Yvette Ntsogo Enguéné, Antimicrobial Agents and Chemotherapy Microbial PathogensMolecular BiologyAntibiotic ResistanceBacterial PathogensDrug Resistance	2015	251
A Two-Component Regulatory System Interconnects Resistance to Polymyxins, Aminoglycosides, Fluoroquinolones, and β-Lactams in <i>Pseudomonas aeruginosa</i> Cédric Muller, Patrick Plésiat, Katy Jeannot Antimicrobial Agents and Chemotherapy Microbial PathogensBacteriologyMolecular BiologyAntibiotic ResistanceBacterial Pathogens	2010	214
Induction of the MexXY Efflux Pump in <i>Pseudomonas aeruginosa</i> Is Dependent on Drug-Ribosome Interaction Katy Jeannot, Mara Sobel, Farid El Garch, Journal of Bacteriology Molecular BiologyAntimicrobial ChemotherapyAntibiotic ResistanceOperon MexxyDrug Resistance	2005	161
Resistance and Virulence of <i>Pseudomonas aeruginosa</i> Clinical Strains Overproducing the MexCD-OprJ Efflux Pump Katy Jeannot, Sylvie Elsen, Thilo Köhler, Antimicrobial Agents and Chemotherapy	2008	123
Cumulative Effects of Several Nonenzymatic Mechanisms on the Resistance of <i>Pseudomonas aeruginosa</i> to Aminoglycosides Farid El'Garch, Katy Jeannot, Didier Hocquet, Antimicrobial Agents and Chemotherapy	2006	108
Multiple Mutations Lead to MexXY-OprM-Dependent Aminoglycoside Resistance in Clinical Strains of Pseudomonas aeruginosa Sophie Guénard, Cédric Muller, Laura Monlezun, Antimicrobial Agents and Chemotherapy GeneticsBacteriologyMolecular BiologyAntibiotic ResistanceAmino Acid Positions	2013	108
<i>Pseudomonas aeruginosa</i> May Accumulate Drug Resistance Mechanisms without Losing Its Ability To Cause Bloodstream Infections Didier Hocquet, P. Berthelot, Micheline Roussel‐Delvallez, Antimicrobial Agents and Chemotherapy Antibiotic ResistanceBacterial PathogensResistance MechanismsDrug ResistanceDisease Resistance	2007	99
Antibiotic Resistance Determinants in a Pseudomonas putida Strain Isolated from a Hospital Lázaro Molina, Zulema Udaondo, Estrella Duque, PLoS ONE Antibiotic ResistanceBacterial PathogensDrug ResistanceDisease ResistanceAntimicrobial Therapy	2014	95
Genetic and Biochemical Characterization of OXA-405, an OXA-48-Type Extended-Spectrum β-Lactamase without Significant Carbapenemase Activity Laurent Dortet, Saoussen Oueslati, Katy Jeannot, Antimicrobial Agents and Chemotherapy Significant Carbapenemase ActivityOxa-48-type Extended-spectrum β-LactamaseBacterial PathogensDrug ResistanceMedical Microbiology	2015	81

Page 1